Title : Matching-adjusted indirect comparison: entrectinib versus crizotinib in ROS1 fusion-positive non-small cell lung cancer.

Pub. Date : 2020 Aug

PMID : 32648475






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Matching-adjusted indirect comparison: entrectinib versus crizotinib in ROS1 fusion-positive non-small cell lung cancer. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens